Drug Development For Contract Phamra

INSIGHTS ON DRUG DEVELOPMENT

Modifying The Micro-Environment To Improve Dissolution Rate
<p>Discover how modifying the micro-environment with targeted excipients can significantly enhance the dissolution rate of poorly soluble drugs using conventional manufacturing methods.</p>
Formulation Development For Therapeutic Oligonucleotides
Discover how expert formulation and analytical support enable the development of stable, injectable oligonucleotide therapies across diverse delivery routes and molecule types.
EMA Support For Rare Disease Therapies
Review how the EMA supports rare disease drug development through regulatory and financial incentives for therapies that meet strict eligibility and ongoing compliance criteria.
The Role Of A Consulting Firm In The IND Process
Navigate the complex IND process with expert guidance and discover how early FDA engagement can accelerate your path to clinical trials.

Choosing The Right PBMCS For Your Research And Product Development Needs
6/10/2025

Enhance the success of your research and cell therapy programs by sourcing PBMCs with proven functional performance and donor-specific insights.
Flow Chemistry Vs. Batch Processes
6/10/2025

Explore how continuous flow chemistry can accelerate your chemical development with greater efficiency, safety, and sustainability compared to traditional batch processes.
Linking Clinical Correlates To Cell Therapy Outcomes
6/9/2025

Streamline cell therapy development by transforming complex cellular characteristics into a predictive, multiparametric metric that guides the selection of high-potential starting material.
Injection Site Reaction Screening Methodology
6/6/2025

Optimize drug formulations for solubility at physiological pH to reduce injection site reactions, enable high-concentration dosing, and enhance patient comfort and compliance.

Your Partner For Timely, Accurate And High-Quality Preclinical Efficacy Studies

By partnering with us, you gain access to cutting-edge facilities and a team of experienced scientists with deep expertise in a wide range of therapeutic areas.
A CDMO With Oral Solid Dose And Sterile Injectable Expertise

Societal specializes in modified-release formulations, including those for high potent and DEA controlled substances.
Bridging Molecules From Early Discovery To POC And Beyond

Learn how this partnership improves flexibility for customers, offers dedicated project teams, and enables a bespoke service that is tailored to each development program.
Protein Analytics

With a suite of analytical services and capabilities, we equip our clients with the insights and tools needed for successful biologics characterization and phase-appropriate process development.
Ready To Meet Your Complex OSD Needs, Seamlessly And Simply

Explore an approach that accelerates your project through key milestones with a technology transfer process that ensures a fast start and process analytical technology that increases efficiency and reduces cost.